髓磷脂碱性蛋白

suǐ lín zhī jiǎn xìnɡ dàn bái
  • myelin basic protein
髓磷脂碱性蛋白髓磷脂碱性蛋白
  1. 原位杂交显示髓磷脂碱性蛋白(MyelinBasicProtein,MBP)的基因表达。

    The expression of myelin basic protein ( MBP ) was examined by in situ hybridization .

  2. S100为该瘤最敏感的标记物,髓磷脂碱性蛋白为最可靠的标记物。

    S 100 is the most sensitve marker of MPNST and myelin basic protein ( MBP ) is the most reliable marker .

  3. 髓磷脂碱性蛋白的提纯及其对PBMC产生TNF和IFN的影响

    The Purification of Myelin Basic Protein and Its Effect on PBMC Producing TNF and IFN

  4. 目的探讨髓磷脂碱性蛋白(MBP)诱导EAE产生的可能原因。

    Objective To explore the possible causes of MBP inducing EAE .

  5. 目的:提取并纯化正常人脑脊髓的髓磷脂碱性蛋白(MBP),鉴定其活性,并用其诱导实验性自身免疫性脑脊髓炎(EAE)大鼠模型。

    Objective : To induce a meliorative model of experimental allergic encephalomyelitis ( EAE ) .

  6. 脊髓横断组髓磷脂碱性蛋白(MBP)阳性的少突胶质细胞数目的时间及空间分布与正常对照组相比无统计学差异(P>0.05)。

    The number of myelin basic protein ( MBP ) immunopositive oligodendrocytes in SCI groups was not obviously different from that in the control group ( P > 0.05 ) .

  7. CNS抗原特异性的T细胞(比如针对髓磷脂碱性蛋白特异性T细胞)在CNS保护和修复的生理过程中起关键作用。

    Studies have been shown that T cells directed to specific CNS antigens , such as myelin basic protein ( MBP ) - T cell , play a key role in the physiological processes of CNS protection and repair .

  8. 髓磷脂碱性蛋白染色观察髓鞘的修复。

    Repair of myelin sheath was observed by MBP staining .

  9. 颅脑损伤患者脑脊液髓磷脂碱性蛋白含量变化及临床意义良性肌痛性脑脊髓炎

    Traumatic Brain Injury Patients with Cerebrospinal Fluid Myelin Basic Protein Content and Clinical Significance

  10. 急性坏死性胰腺炎大鼠脑脊液髓磷脂碱性蛋白水平变化的初步研究

    Elevated levels of myelin basic protein in the cerebrospinal fluid of rats with acute necrotizing pancreatitis

  11. 髓磷脂碱性蛋白促进单个核细胞对内皮细胞的粘附效应

    Myelin basic protein promote the effect of peripheral blood mononuclear cells adhesion to human umbilical vein endothelial cells

  12. 目的:探讨脑卒中急性期脑脊液中髓磷脂碱性蛋白抗体浓度与神经功能预后,肢体瘫痪程度和病程的关系。

    AIM : To study the association of neural functional prognosis , degree of extremity hemiplegia , and course of disease with concentration of myelin basic protein antibody in cerebrospinal fluid in patients with acute stroke .